Form 4: Amedisys Director Sells Shares Post-UnitedHealth Merger

Amedisys Director Molly Joel Coye reported the disposition of all her shares following the company's acquisition by UnitedHealth Group for $101 per share.

Summary

• Molly Joel Coye, a Director of Amedisys Inc. (AMED), reported the disposition of 8,818 shares of common stock.
• This transaction occurred on August 14, 2025, coinciding with the acquisition of Amedisys by UnitedHealth Group Incorporated.
• Under the merger agreement, each outstanding Amedisys common stock share was converted into the right to receive $101 in cash.
• The reported shares include 1,690 time-based Restricted Stock Units (RSUs) that were converted into the cash merger consideration.
• Following the transaction, Molly Joel Coye's beneficial ownership in Amedisys Inc. is 0 shares.

Sentiment

Score: 7

Explanation: The filing reports the successful completion of a previously announced merger, which is a positive outcome for the acquired company's shareholders, including the reporting person who received cash for their shares. The transaction was expected.

Positives

• The completion of the merger provides Amedisys shareholders, including the reporting person, with a cash consideration of $101 per share.
• The merger signifies a successful exit for Amedisys shareholders.

Negatives

• Amedisys Inc. ceases to be an independent publicly traded entity, resulting in the delisting of its common stock.
• The reporting person no longer holds any beneficial ownership in the company.

Industry Context

The acquisition of Amedisys by UnitedHealth Group signifies further consolidation within the healthcare services sector, particularly in home health and hospice care. This trend reflects larger healthcare providers seeking to expand their continuum of care offerings and achieve greater scale.

Stakeholder Impact

• Shareholders: Amedisys shareholders received $101 per share in cash, representing a liquidity event and a premium for their investment.
• Employees: Amedisys employees now work for a subsidiary of UnitedHealth Group, potentially leading to integration and operational changes.
• Customers: Amedisys's home health and hospice services will now be part of UnitedHealth Group's broader healthcare offerings, potentially impacting service delivery or integration with other UnitedHealth services.

Next Steps

• Amedisys Inc. will operate as a wholly owned subsidiary of UnitedHealth Group.
• Amedisys common stock will be delisted from public trading.

Key Dates

Keywords

Amedisys, AMED, UnitedHealth Group, Merger, Acquisition, Form 4, Director Share Sale, Healthcare, Home Health, Hospice